Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

被引:0
|
作者
Schnittman, Samuel R. [1 ]
Byakwaga, Helen [2 ]
Boum, Yap [2 ]
Kabakyenga, Jerome [2 ]
Matthews, Lynn T. [3 ]
Burdo, Tricia H. [4 ]
Huang, Yong [1 ]
Tracy, Russell P. [5 ]
Haberer, Jessica E. [6 ,7 ]
Kembabazi, Annet [2 ]
Kaida, Angela [8 ]
Moisi, Daniela [9 ]
Lederman, Michael M. [9 ]
Bangsberg, David R. [2 ,10 ,11 ]
Martin, Jeffrey N. [1 ]
Hunt, Peter W. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Mbarara Univ Sci & Technol, Mbarara, Uganda
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[5] Univ Vermont, Burlington, VT USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
[7] Harvard Univ, Boston, MA 02115 USA
[8] Simon Fraser Univ, Vancouver, BC, Canada
[9] Case Western Reserve Univ, Cleveland, OH 44106 USA
[10] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[11] Portland State Univ, Sch Publ Hlth, Portland, OR 97207 USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2021年 / 8卷 / 06期
基金
美国国家卫生研究院;
关键词
HIV; indoleamine 2,3-dioxygenase-1; inflammation; kynurenine/tryptophan ratio; pregnancy; ISONIAZID PREVENTIVE THERAPY; ANTIRETROVIRAL THERAPY; PREDICT MORTALITY; SOLUBLE CD163; D-DIMER; SUBCLINICAL ATHEROSCLEROSIS; TRYPTOPHAN CATABOLISM; KYNURENINE PATHWAY; WOMEN; BIOMARKERS;
D O I
10.1093/ofid/ofab245
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pregnant women with HIV (PWWH) have high postpartum morbidity and mortality from infections like tuberculosis. Immunologic changes during pregnancy and postpartum periods may contribute to these risks, particularly the immunoregulatory kynurenine pathway of tryptophan catabolism, which contributes to both HIV and tuberculosis pathogenesis and increases in the early postpartum period. Methods. Women with HIV initiating antiretroviral therapy (ART) in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort who were pregnant at enrollment or became pregnant during observation were studied (n = 54). Plasma kynurenine/tryptophan (KT) ratio, soluble CD14 (sCD14), sCD163, sCD27, interferon-inducible protein 10 (IP-10), D-dimer, interleukin-6, and intestinal fatty-acid binding protein levels were assessed through the first year of ART and at 3-month intervals throughout pregnancy and 1 year postpartum. Biomarker changes were assessed with linear mixed models adjusted for ART duration. Hemoglobin concentration changes were used to estimate pregnancy-related changes in plasma volume. Results. The median pre-ART CD4 count was 134. D-dimer increased through the third trimester before returning to baseline postpartum, while most other biomarkers declined significantly during pregnancy, beyond what would be expected from pregnancy-associated plasma volume expansion. IP-10 and sCD14 remained suppressed for at least 12 months postpartum. KT ratio was the only biomarker that increased above prepregnancy baseline postpartum (mean + 30%; P < .001) and remained higher than baseline for >= 9 months (P <= .045 for all time points). Conclusions. Several immune activation markers decline during pregnancy and remain suppressed postpartum, but the kynurenine pathway of tryptophan catabolism increases above baseline for >= 9 months postpartum. The mechanisms underlying postpartum kynurenine pathway activity are incompletely understood but may contribute to increased tuberculosis risk in this setting.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] An examination of changes in maternal neuroimmune function during pregnancy and the postpartum period
    Sherer, Morgan L.
    Posillico, Caitlin K.
    Schwarz, Jaclyn M.
    BRAIN BEHAVIOR AND IMMUNITY, 2017, 66 : 201 - 209
  • [22] Immune activation and cardiovascular disease in chronic HIV infection
    Longenecker, Chris T.
    Sullivan, Claire
    Baker, Jason V.
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (02) : 216 - 225
  • [23] AUTOIMMUNITY DURING PREGNANCY AND THE POSTPARTUM PERIOD
    FEDERLIN, K
    BECKER, H
    MEDIZINISCHE WELT, 1991, 42 (01): : 21 - 25
  • [24] Neuroimaging During Pregnancy and the Postpartum Period
    Jamieson, Dara G.
    McVige, Jennifer W.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2021, 48 (01) : 97 - 129
  • [25] Screening for bipolar disorder during pregnancy and the postpartum period
    Chessick, Cheryl Ann
    Dimidjian, Sona
    ARCHIVES OF WOMENS MENTAL HEALTH, 2010, 13 (03) : 233 - 248
  • [26] Catatonia during pregnancy and the postpartum period
    Csihi, Levente
    Ungvari, Gabor S.
    Caroff, Stanley N.
    Mann, Stephan C.
    Gazdag, Gabor
    SCHIZOPHRENIA RESEARCH, 2024, 263 : 257 - 264
  • [27] Screening for bipolar disorder during pregnancy and the postpartum period
    Cheryl Ann Chessick
    Sona Dimidjian
    Archives of Women's Mental Health, 2010, 13 : 233 - 248
  • [28] Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
    Cha, Lilian
    Berry, Cassandra M.
    Nolan, David
    Castley, Allison
    Fernandez, Sonia
    French, Martyn A.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2014, 3
  • [29] Changes in physiology and immune system during pregnancy and coronavirus infection: A review
    Chen, Miaomiao
    Zeng, Jing
    Liu, Xiyao
    Sun, Guoqiang
    Gao, Ying
    Liao, Jiujiang
    Yu, Jiaxiao
    Luo, Xin
    Qi, Hongbo
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 255 : 124 - 128
  • [30] Pelvic floor changes in the first term pregnancy and postpartum period
    Wu, Emily
    Kuehl, Thomas J.
    Gendron, Jilene M.
    White, Wendy
    Yandell, Paul M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (07) : 1897 - 1905